Intellego Technologies AB Stock

Equities

INT

SE0016075063

Biotechnology & Medical Research

Delayed Nasdaq Stockholm 04:17:41 2024-04-30 am EDT 5-day change 1st Jan Change
30.35 SEK +5.02% Intraday chart for Intellego Technologies AB +8.01% +79.59%
Sales 2021 9.51M 865K Sales 2022 59.22M 5.39M Capitalization 239M 21.77M
Net income 2021 -3M -273K Net income 2022 -9M -819K EV / Sales 2021 35 x
Net cash position 2021 8.24M 750K Net cash position 2022 24.21M 2.2M EV / Sales 2022 3.63 x
P/E ratio 2021
-86.1 x
P/E ratio 2022
-22.8 x
Employees 68
Yield 2021 *
-
Yield 2022
-
Free-Float 94.77%
More Fundamentals * Assessed data
Dynamic Chart
Intellego Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Intellego Technologies Obtains Up to SEK40 Million Credit Line Ahead of New Product Launches MT
Intellego Technologies AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Intellego Technologies AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Intellego Technologies AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Intellego Technologies AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Certain Shares of Intellego Technologies AB are subject to a Lock-Up Agreement Ending on 24-DEC-2022. CI
Intellego Technologies AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Intellego Technologies AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Intellego Technologies AB (OM:INT) agreed to acquire Daro Group Limited for ú10 million. CI
Intellego Technologies AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Intellego Technologies AB (OM:INT) signed letter of intent to acquire majority stake in Jiangyin Feiyang Instrument Co., Ltd CI
Intellego Technologies AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 CI
Intellego Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Certain Shares of Intellego Technologies AB are subject to a Lock-Up Agreement Ending on 24-DEC-2021. CI
More news
1 day+5.02%
1 week+8.01%
Current month+3.23%
1 month+2.53%
3 months+102.33%
6 months+89.45%
Current year+79.59%
More quotes
1 week
25.60
Extreme 25.6
31.90
1 month
24.70
Extreme 24.7
31.90
Current year
13.44
Extreme 13.44
31.90
1 year
9.80
Extreme 9.8
34.50
3 years
4.00
Extreme 4
34.50
5 years
4.00
Extreme 4
34.50
10 years
4.00
Extreme 4
34.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 11-08-30
Director of Finance/CFO 52 22-01-23
Sales & Marketing - 20-12-31
Members of the board TitleAgeSince
Chairman 67 -
Director/Board Member 77 16-12-31
Director/Board Member - -
More insiders
Date Price Change Volume
24-04-30 30.35 +5.02% 541 507
24-04-29 28.9 +3.58% 510,433
24-04-26 27.9 -0.36% 60,450
24-04-25 28 +1.45% 94,388
24-04-24 27.6 -1.78% 59,089

Delayed Quote Nasdaq Stockholm, April 30, 2024 at 04:17 am EDT

More quotes
Intellego Technologies AB is a Sweden-based company engaged in photochromatic indicator technology. The Company is a manufacturer of colorimetric ultraviolet indicators. UVC Dosimeters are used in Healthcare, Hospitality, Retail, Transportation and Commercial Applications around the world. With its patented photochromic ink that changes color based on exposure to ultraviolet irradiation or specific substances, Intellego produces dosimeters in a variety of formats and custom options to meet the constantly evolving needs of Ultraviolet Device Manufacturers (OEMs) and end-users. Intellego Technologies is headquartered in Stockholm, with product development and manufacturing based in the southwest region of Sweden.
Calendar
More about the company